Clinical Trials Logo

BPH With Urinary Obstruction clinical trials

View clinical trials related to BPH With Urinary Obstruction.

Filter by:

NCT ID: NCT06101576 Recruiting - Clinical trials for BPH With Urinary Obstruction

Readmission Following Prostatic Surgery

Start date: January 1, 2005
Phase:
Study type: Observational

This study will be conducted to estimate readmission rate and reasons for readmission after all modalities of endoscopic transurethral surgeries for treatment of BOO secondary to BPH in the last 20 years.

NCT ID: NCT06037356 Recruiting - Clinical trials for BPH With Urinary Obstruction

PUL vs TURP in BPH Patients With Urinary Retention

PULTUR
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The study will be a prospective, randomized controlled trial comparing prostatic urethral lift (PUL) versus transurethral resection of prostate (TURP) in benign prostate hyperplasia (BPH) patients with urinary retention. The primary objective of this study is to compare the catheter-free rates of PUL vs TURP. Secondary objectives include comparison of complications rates, cost effectiveness, patient satisfactory, symptom scores, quality of life measures and urodynamic parameters.

NCT ID: NCT05652023 Recruiting - Overactive Bladder Clinical Trials

Noninvasive Ultrasound Assessment of Detrusor Dysfunction

NUADD
Start date: April 20, 2023
Phase:
Study type: Observational

The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.

NCT ID: NCT05620784 Recruiting - BPH Clinical Trials

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

Start date: March 1, 2023
Phase: Phase 3
Study type: Interventional

Holmium Laser Enucleation of the Prostate (HoLEP) is a size-independent treatment option for benign prostatic hypertrophy (BPH) as recommended by the American Urological Association (AUA) Guidelines. Loop diuretics (furosemide) have been given historically during the morcellation portion of HoLEP to promote urine production in the post-operative setting and to minimize the impact of fluid absorption during long periods of morcellation. The intra-operative use of 20mg IV furosemide in perioperative HoLEP pathways has been propagated with the dissemination of HoLEP across North America without evidence to support its routine administration. With increasing surgical efficiency from improvements in laser and morcellator technology, the role of intra-operative furosemide is unknown. This study is designed to assess if there is a significant difference in same day discharge rates after Holmium Laser Enucleation of the Prostate (HoLEP) with and without IV furosemide. .

NCT ID: NCT04935151 Completed - Male Clinical Trials

HoLEP vs BPRP in the Management of a Large Volume (> 80 gm) Symptomatic BPH

Start date: December 4, 2016
Phase: N/A
Study type: Interventional

To compare bipolar resection versus holmium laser enucleation for management of symptomatic large BPH (> 80 gm)

NCT ID: NCT04143399 Completed - Male Clinical Trials

HoLEP vs BPRP of a Large Volume BPH: a Randomised Controlled Trial

Start date: February 14, 2016
Phase: N/A
Study type: Interventional

To compare bipolar resection versus holmium laser enucleation for management of large BPH.

NCT ID: NCT04102566 Recruiting - Pain Clinical Trials

Optimizing Pain Control in Transurethral Resection of the Prostate

Start date: December 8, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to develop a multi-modal protocol for pain management after TURP that minimizes opioid use. The investigators hypothesize this approach will provide non-inferior pain control to the current standard of care which includes opioids as the primary agent. The investigators believe this is an important step in reducing the opioid epidemic in surgical patients.

NCT ID: NCT03998150 Completed - Male Clinical Trials

Holmium Laser vs Bipolar Enucleation of a Large Volume BPH: a Randomised Controlled Study

BPH
Start date: November 1, 2016
Phase: N/A
Study type: Interventional

To compare bipolar plasmakinetic enucleation versus holmium laser enucleation for management of large BPH.

NCT ID: NCT03605745 Terminated - BPH Clinical Trials

Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL)

Rezum XL
Start date: June 19, 2018
Phase: N/A
Study type: Interventional

Prospective, multicenter, single arm clinical trial designed to evaluate the safety of the Rezūm System in treating subjects with symptomatic BPH for prostate sizes >80cm3 and ≤150 cm3.

NCT ID: NCT03589196 Enrolling by invitation - Clinical trials for Prostatic Hyperplasia

Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT

EPPROSTATECT
Start date: March 10, 2018
Phase: N/A
Study type: Interventional

To Evaluate and compare the outcome and coast of ejaculation sparing management of BPH using 3 different techniques: PVP, PKVP and TURP. Ejaculation sparing TURP group is considered the standard control group. Evaluation will be carried out through a prospective randomized powered trial